The Experimental Drug Development Centre (EDDC) is Singapore’s national platform for drug discovery and development. Our goals are to champion local translational drug development efforts and thus catalyze the growth of Singapore’s biopharma ecosystem. With a focus on Asian-prevalent diseases, we aim to develop therapeutics and diagnostics that save and improve the lives of patients in Singapore, Asia, and the world beyond. We are dedicated to translating the great science arising from Singapore’s biomedical and clinical research into innovative healthcare solutions. EDDC possesses a full range of capabilities for the discovery and development of small molecule drugs, antibody-based drugs, and companion diagnostics. We are keen to establish robust partnerships with academic, clinical, and bio-pharmaceutical industry partners for development and commercialization of innovative assets and platforms. EDDC is committed to jointly bring forward medicines that improve healthcare and generate a return to support Singapore’s future drug discovery and development research.